From GlobeNewswire: 2024-11-18 09:22:00

Global Microbiology CRO Services Market is booming due to increased outsourcing of clinical studies and rising R&D investments. The report forecasts market growth to reach US$ 11.51 billion by 2031 at a CAGR of 9.6%. Major players offer a range of services crucial for pharmaceutical, biotech, and medical device industries success.

Outsourcing clinical trials to CROs is on the rise, with ~75% of trials handled by CROs in 2022. This trend ensures efficient and cost-effective operations, boosts cost-effectiveness, and reduces errors. Microbial testing is crucial in clinical trials, driving the microbiology CRO market. Advancements in testing tech are enhancing accuracy and speed in microbiology testing.

North America led the microbiology CRO services market in 2023, with Asia Pacific expected to show the highest growth. Market segmentation includes clinical, medical device, and other applications, with microbial testing being the largest service type. Microbes, end-users, and regions are also key segments shaping the market landscape.

Key players like Microbiologics, Melbec Microbiology, and TheraIndx Lifesciences Pvt. Ltd. drive innovation in the microbiology CRO services market. Trending topics include clinical CROs, pre-clinical services, and contract development organizations. Recent headlines highlight the launch of new services and advancements in microbiology technology.

The global microbiology CRO services market is poised for substantial growth, driven by increasing regulatory complexity and demand for safer pharmaceuticals and medical devices. Research and development investments are fueling market expansion, with personalized medicine and biologics playing a significant role in shaping the industry’s future.



Read more at GlobeNewswire: Microbiology CRO Services Market Size to Reach USD 11.51